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Etoposide is a widely prescri�ed and potent anti-
cancer drug �elonging to DNA topoisomerase II inhi�i-
tors�� which sta�ilize enzyme-DNA cleavage complexes 
forming nonrepaira�le protein-linked DNA dou�le 
strand �reaks [��� �]. The cells injured in such a way 
are finally eliminated �y apoptosis. 
Although the most efficacious chemotherapeutic 
regimens for utilizing DNA topoisomerase II inhi�itors 
were developed over the past several years�� their use-
fulness has �een limited �y the frequent development 
of drug resistance. Chemosensitization consisting in 
using one drug or agent to render cancer cells more 
suscepti�le to a second agent represents the novel 
strategy to enhance the effects of cytotoxic thera-
peutics [3]. 
During the past decade�� the search of novel su�-
stances with considera�le potential for chemosensiti-
zation was advantageous in revealing the compounds 
of natural origin possessing the a�ility of enhancing 
the cytotoxic activity of chemotherapeutics. For ex-
ample�� deguelin�� a plant-derived su�stance�� markedly 
enhances chemosensitivity of human leukaemia cells 
to etoposide or cytara�ine [4]. Recently�� the polysac-
charides and peptides�� isolated from seaweeds have 
�ecome a matter of great interest for cancer therapy. 
The mechanisms of their anticancer activity are related 
to their a�ility to suppress the growth of cancer cells 
�cytotoxic or cytostatic effects���� to enhance the im-
mune responses�� and to inhi�it tumor angiogenesis 
[���]. �everal marine algal polysaccharides�� fucoi-
dans in particular�� have �een found to induce apopto-
sis in cancer cells [����]. Nevertheless�� the question 
whether these su�stances are a�le to modulate the 
apoptosis induced �y chemotherapeutic agents has 
�een yet unresolved. Com�ining fucoidan with etopo-
side may �e a novel strategy that has the potential for 
improving the antineoplastic activity of etoposide. This 
study was designed to test this hypothesis.
MATERIALS AND METHODS
Materials and reagents. Far-eastern �rown sea-
weeds F. evanescens�� which have �een collected in 
Okhotsk �ea in August ������ were used in this study. 
Etoposide was purchased from Brystol-Myers �qui�� 
�pA �Italy��. 
Extraction and purification of fucoidan. Fucoi-
dan from F. evanescens was prepared as descri�ed 
in [��]. After removal of small shells and mechanical 
impurities�� fresh seaweed F. evanescens ��� kg�� was 
extracted with ethanol at a �:� ratio at temperature 
of �� °C for �4 h. The extract was separated and 
ethanol was evaporated to o�tain a concentrate of 
�iologically active low-molecular su�stances. The 
processed seaweeds were dried and extracted with 
�.� M solution of hydrochloric acid �pH �.���.��� for 
�� h at ����� °C. The extract was concentrated up 
to ��% of initial volume �y ultrafiltration�� neutralized 
to pH 6.� and evaporated up to � L. The concentrate 
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was further neutralized and precipitated with two vol-
umes of ethanol. The precipitate was washed out with 
�6% ethanol and dried. Molecular weigth of fucoidan 
from F. evanescens was ����� kDa; with the follow-
ing monosaccharide content �%��: Fuc — ��4�� Xyl — 6�� 
Man — ��� Glc — 4�� Gal — ��; Fuc:�O4
�� mol/mol — �: 
����������. For cell culture experiments�� the aqueous 
stock solution of fucoidan was prepared at � mg/ml 
and sterilized in �oiling water �ath. The solution was 
stored at 4 °C prior to the use.
Cell culture and morphology. Human T-acute 
leukemia cell line MT4 and B-cell lymphoma line Na-
malwa were o�tained from the National Collection of 
Cell Lines at the Institute of Experimental Pathology�� 
Oncology and Radio�iology �Kyiv�� Ukraine��. The cells 
were grown in suspension in RPMI-�64� culture me-
dium ��igma Chem. Co.�� U�A���� supplemented with 
��% fetal �ovine serum ��igma Chem. Co.�� in �% 
CO� — ��% air atmosphere at 3�� °C and ���% humid-
ity. Cells were su�cultured once in 3 days �y dilution 
with the fresh medium. Cell via�ility was evaluated in 
hemocytometer after staining with �.�% Trypan �lue. 
For studying cell morphology�� cells were cytospined 
and stained �y May—Grunwald—Giemsa technique.
Detection of apoptotic cells. Apoptotic cells with 
hypodiploid DNA content were detected as previously 
reported [�3]. In �rief�� cells in exponential growth 
phase were incu�ated with ��� µg/ml fucoidan for 
the time  indicated followed �y �� h incu�ation with 
etoposide at a dose of 4 µg/ml �MT-4 cells�� or 4� µg/ml 
�Namalwa cells��. The cells were washed with ice-cold 
PB��� harvested and stained with �� µg/ml propidium 
iodide �PI�� in phosphate-�uffered saline containing 
�.�% sodium citrate�� �.�% Triton X-����� and �� µg/ml 
RNase A. The DNA content of cells was analyzed with 
FAC�can flow cytometer �Becton Dickinson�� U�A��. The 
relative apoptotic index was calculated as follows: 
Apoptotic percentage in presence of inducer —  
Spontaneous apoptotic percentage
————————————————————————————————————————————————————— x 100%.
100% — Spontaneous apoptotic percentage
Caspase-3 activation assay. The percentage 
of cells expressing active form of caspase-3 was 
assessed �y flow cytometry with the use of a FITC-
conjugated monoclonal active caspase-3 anti�ody 
kit �Becton Dickinson Biosciences�� U�A��. MT-4 or 
Namalwa cells were pretreated with fucoidan and in-
cu�ated with or without etoposide as indicated a�ove. 
The cells were collected and rinsed with ice-cold PB�. 
Then these cells were permea�ilized and immunos-
tained according to the procedure recommended �y 
the manufacturer. Data were analyzed �y using Cell-
Quest software �BD Biosciences�� U�A��.
Statistical analysis. The �tudent t test was used 
to analyze the data. P value of < �.�� was considered 
statistically significant.
RESULTS
The incu�ation of �oth MT-4 and Namalwa cells in 
the presence of fucoidan at the doses up to ��� µg/ml 
did not affect cell growth kinetics �Fig. ���.
 
Fig. 1. Effect of fucoidan on growth of MT-4 �a�� and Namalwa �b�� 
cells. Fucoidan was added at ��� µg/ml. Each experiment was 
performed in triplicate and mean ± �.D. is indicated.
At this maximal dose �eing assayed�� fucoidan 
did not increase the percentage of apoptotic cells 
in �oth cell lines upon ��-hour treatment. Moreover�� 
no apoptotic effect was evident when the cells were 
incu�ated in the presence of fucoidan for �4 days with 
fresh fucoidan solution �eing added each time the cells 
were su�cultured �Fig. ��� a��. Upon such a long-term 
treatment with fucoidan�� cell morphology remained 
unaltered �data not shown��.
Pre-incu�ation with ��� µg/ml fucoidan for �� h 
followed �y apoptosis induction with etoposide has 
resulted in a�out twice as much increase in the per-
centage of hypodiploid MT-4 cells as compared to 
the cells treated with etoposide alone. The sensitiza-
tion effect of the same magnitude was also evident 
in MT-4 cells incu�ated with ��� µg/ml fucoidan for 
�4 days followed �y apoptosis induction with etoposide 
�see Fig. ��� a��. When Namalwa cells were assayed in 
the similar experimental setting�� the percentage of 
hypodipoid cells upon etoposide treatment of control 
culture did not differ significantly from that in the cul-
ture pre-incu�ated with fucoidan �Fig. ��� b��. No effects 
of sensitization in Namalwa cells could �e detecta�le 
upon long-term pretreatment with fucoidan. 
Because caspase activation is known to �e involved 
in etoposide-induced apoptosis [�4]�� we attempted to 
evaluate the percentage of MT-4 cells with the active 
form of caspase-3 upon their treatment with etoposide 
alone or etoposide treatment following pre-incu�ation 
with fucoidan. As illustrated in Fig. 3�� the increase in 
apoptotic cell percentage in MT-4 cells treated with 
etoposide after their preincu�ation with fucoidan was 
not accompanied �y further increase in caspase-3-
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positive cells as compared with the cells treated with 
etoposide only.
Fig. 2. Relative apoptotic index in MT-4 �a�� or Namalwa �b�� 
cells treated with fucoidan �� — ��� µg/ml �� h�� � — ��� µg/ml 
�4 days���� etoposide �3���� fucoidan �� h + etoposide �4���� fucoi-
dan �4 days + etoposide ����. The concentration of etoposide 
was 4 µg/ml in a and 4� µg/ml in b. Each experiment was 
performed in triplicate and mean ± �.D. is indicated
*p < �.�� vs etoposide alone.
DISCUSSION
Fucoidans are major sulfated polysaccharides of 
the �rown seaweed possessing the wide spectrum of 
�iological activities. There have �een many reports on 
anti-tumor effects of fucoidan [6�� ���� ������]. Recently�� 
it has �een demonstrated that fucoidan may induce 
apoptosis of cancer cell acting via caspase-3 and -�� 
activation-dependent pathway and down-regulation of 
ERK pathways �decreased phosphorylation of ERK and 
G�K�� �ut not p3� or Akt�� [���� ��]. Nevertheless�� in our 
study fucoidan from far-eastern �rown seaweeds F. eva­
nescens did not possess apoptogenic activity in two 
lines of human lymphoid malignant cells even upon the 
prolonged treatment at a concentration of ��� µg/ml. 
Our data are in line with the results presented recently 
�y Teruya et al. [��] who demonstrated that the native 
non-modified fucoidan from Cladosiphon okamuranus 
did not decrease cell via�ility of U�3�� cells. 
�ince fucoidan assayed in our study was not capa�le 
of inducing apoptosis�� we have attempted to investigate 
whether or not fucoidan could enhance the sensitivity 
to etoposide of two lines of human lymphoid malignant 
cells. Earlier we have shown that MT-4 and Namalwa 
cells are characterized �y different intrinsic suscepti�il-
ity to apoptosis induction �y etoposide [�3]. Therefore�� 
etoposide dose in our experiments in Namalwa cells was 
ten-fold as large as that used for apoptosis induction 
in MT-4 cells providing for a�out the same apoptotic 
percentage in �oth cell lines assayed. In MT-4 cells�� 
fucoidan was shown to �e effective as sensitizer to-
wards the apoptogenic effects of etoposide providing 
for two-fold increase in the apoptotic cell percentage. 
The sensitization activity of fucoidan was assessed in 
cells pretreated for �� h or �4 days. The trend of incre-
ment of apoptotic cell percentage with the increasing 
pre-incu�ation time was demonstrated although the 
difference was not significant. In contrast�� pretreat-
ment with fucoidan did not affect the suscepti�ility of 
Namalwa cells to etoposide. 
Caspases are known to �e crucial mediators of 
apoptosis �see review [��] for details��. To �etter under-
stand the pro�a�le mechanisms of the apoptosis en-
hancement �y fucoidan�� in particular the mechanisms 
related to caspase-dependent pathway of apoptosis 
induction in MT-4 cells�� we tried to assess the involve-
ment of caspase-3 in sensitization effect of fucoidan 
in etoposide-induced apoptosis. While etoposide 
treatment of MT-4 cells resulted in the pronounced 
caspase-3 activation�� the apoptosis enhancement �y 
fucoidan was not accompanied �y further increase 
in the content of active form of caspase-3. �everal 
explanations of this fact could �e put forward. The 
optimal apoptosis induction in MT-4 cells�� especially 
in case of etoposide dose �elow LD�� may require 
Fig. 3. Active form of caspase-3 in MT-4 cells. a — control �without treatment��; b — fucoidan for �� h; c — etoposide 4 µg/ml; 
d — fucoidan �� h + etoposide 4 µg/ml. The figures show representative staining profiles for ������� cells per experiment. M� is the 
cell population defined as caspase-3-positive
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some specified level of caspase-3 activation �a�out 
3�% according to our data���� while further increment 
in caspase-3 activation may �e redundant. Moreover�� 
other proteases are certainly involved in the realization 
of etoposide-induced apoptosis. The elucidation of the 
apoptosis-related intracellular targets of fucoidan will 
�e addressed in future studies.
 In summary�� we demonstrated�� to our knowledge 
for the first time�� that fucoidan significantly sensitized 
human leukemia MT-4 cells to death induced �y DNA 
topoisomerase II inhi�itor etoposide. This activity of 
fucoidan does not seem to �e related to caspase-3 
activation-dependent pathway. �ince in Namalwa cells 
the sensitization effects of fucoidan were not evident�� 
tumor cell of different origin should �e investigated 
with regard to the cooperative role of fucoidan with 
topoisomerase II inhi�itors.
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ПОВЫШЕНИЕ ЧУВСТВИТЕЛЬНОСТИ ЗЛОКАЧЕСТВЕННЫХ 
ЛИМФОИДНЫХ КЛЕТОК ЧЕЛОВЕКА К ЭТОПОЗИДУ 
ПРИ ДЕЙСТВИИ ФУКОИДАНА ПОЛИСАХАРИДА бУРЫХ 
ВОДОРОСЛЕЙ
Одной из важных задач современной стратегии противоопухолевой терапии является поиск веществ, повышающих 
чувствительность опухолевых клеток к индукции апоптоза под действием химиопрепаратов. Цель: изучение апоптогенной и 
апоптозмодулирующей активности фукоидана — сульфатированного полисахарида, выделенного из дальневосточной бурой 
водоросли Fucus evanescens, на двух линиях злокачественных лимфоидных клеток человека MT-4 и Namalwa. Методы: апоптоз 
выявляли морфологически и количественно проточной цитометрией клеток, окрашенных йодистым пропидием. Активацию 
каспазы-3 изучали методом проточной цитометрии клеток после реакции с конъюгированными моноклональными антителами. 
Результаты: фукоидан в дозе 500 мкг/мл не проявлял токсичности в клетках MT-4 или Namalwa даже при длительном 
присутствии препарата в культурах до 14 сут. Предварительная инкубация клеток MT-4 с фукоиданом в указанной дозе 
приводила к двукратному повышению относительного апоптотического индекса при действии ингибитора ДНК топоизомеразы II 
этопозида, причем такого эффекта в клетках Namalwa не отмечено. Повышение апоптотического индекса в клетках MT-4 
под влиянием фукоидана при индукции апоптоза этопозидом не сопровождалось приростом процентного содержания клеток с 
активной формой каспазы-3, в сравнении с таковым при действии одного лишь индуктора апоптоза этопозида. Выводы: впервые 
продемонстрирована способность фукоидана усиливать этопозидиндуцированный каспазозависимый апоптоз в клетках MT-4. 
Подобный эффект отсутствовал в клетках Namalwa. Механизм повышения чувствительности злокачественных лимфоидных 
клеток человека к этопозиду при действии фукоидана, по-видимому, напрямую не связан с активацией каспазы-3.
Ключевые слова: фукоидан, бурые водоросли, апоптоз, линии злокачественных лимфоидных клеток человека, этопозид, 
каспаза-3. 
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